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Rapid adherent cellsAbstract Background: Although several approaches for identification and isolation of
carcinoma cells with tumour initiating properties have been established, enrichment of a
population of pure and viable tumour-initiating cells (TICs) is still problematic. This study
investigated possibilities to isolate a population of cancer cells with tumour initiating
properties based on their adherence properties, rather than expression of defined markers
or clonogenicity.
Methods: Several human cell lines derived from oral dysplasia and oral squamous cell carci-
noma (OSCC), as well as primary cells derived from patients with OSCC were allowed to
adhere to collagen IV-coated dishes sequentially. Rapid adherent cells (RAC), middle adher-
ent cells (MAC) and late adherent cells (LAC) were then harvested and further investigated for
their morphology, stem cell-like properties and molecular profile while grown in vitro and
tongue xenotransplantation in NOD-SCID mice at serial dilutions.
Results: RAC showed significantly higher colony forming efficiency (p < 0.05), sphere forming
ability, greater migration ability (p < 0.05), exhibited longer G2 phase and displayed higher
expression of integrin b1 and other stem-cell related molecules as compared to MAC and
LAC. RAC induced tongue tumours in NOD-SCID mice with the highest incidence. These
tumours were also bigger and metastasised more frequently in loco-regional lymph nodes than
MAC and LAC.
X. Liang et al. / European Journal of Cancer 50 (2014) 3262–3270 3263Conclusions: These findings prove for the first time that OSCC cells with tumour initiating
properties can be enriched based on their rapid adhesiveness to collagen IV. This separation
procedure provides a potentially useful tool for isolating TICs in OSCC for further studies on
understanding their characteristics and drug-resistant behaviour.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Oral squamous cell carcinoma (OSCC) has poor
prognosis due to therapy-resistant loco-regional recur-
rences and distant metastases [1]. The cancer stem cell
theory, although controversial, seems to explain well
the behaviour of this disease, and the existence of a sub-
population of cells with tumour initiating properties and
increased self-renewal has been shown in OSCC [2].
Understanding the biology of tumour initiating cells
(TICs) is thus essential for better understanding and
more specific targeting of OSCC. For the same reason,
robust methods for isolation of TICs are in demand.
Numerous strategies for enrichment of TICs have been
previously described [2–5]. However, isolating a popula-
tion of pure and viable putative TICs is still problem-
atic. Fluorescence-activated cell sorting (FACS) is the
most common technique to isolate TICs based on spe-
cific surface makers, and CD44 has been repeatedly
reported to identify human oral cancer stem cells [2,4].
Nevertheless, there is no single marker that can be used
for isolation of TICs for any type of cancer, including
OSCC, because of tumour heterogeneity and lack of
reproducibility [5]. Moreover, the FACS technique
requires high-cost, high-speed sorters and high-quality
antibodies. Sorting the side population (SP) on the basis
of the ability to efflux the fluorescent DNA-binding dye
Hoechst 33342, or sorting of cells based on the ALDH1
enzymatic activity has also been used for isolation of
TICs, but sometimes only few cells are acquired by these
methods, and thus they are hardly of any use for further
investigations [5]. In addition, the method of sorting SP
cells cannot be applied broadly since not all cell lines
contain SP cells [6]. Recent studies that explored more
functional, non-invasive alternative methods to FACS
analysis, demonstrated that non-adherent sphere forma-
tion [3], in vivo serial tumour xenotransplantation [7], as
well as chemotherapeutic drug resistance [7,8] could be
used to enrich a subpopulation with TICs. However,
these methods require a long time to yield TICs, and
not all cell types and cell lines are able, for example,
to grow as spheres. In this study we have assessed the
potential of a functional approach for TIC isolation in
OSCC, a method previously used for normal epithelium
[9]. Although severely disturbed, OSCC has an organisa-
tion resembling the normal oral epithelium, including
functionally different cell sub-populations: stem cells,
transient amplifying cells and terminally differentiatedcells [10]. Based on the ability of normal epidermal stem
cells to rapidly adhere to basement membrane molecules
such as collagen IV due to their differential expression of
specific integrins [11], an adhesion assay for their isola-
tion and enrichment was successfully developed in both
human [11], murine [12], and rabbit normal epithelium
[9]. We have adopted this method of isolating stem cells
in normal epithelia for enrichment of TICs in OSCC,
and determined whether a sub-population of cancer cells
containing putative TICs could be separated over time
according to adhesiveness to collagen IV. We report
here, for the first time to our knowledge, that
sub-populations of cells enriched for TICs, with
increased self-renewal and higher tumourigenic poten-
tial could be isolated within 10 min using the method
of rapid adhesiveness to collagen IV in OSCC.
2. Materials and methods
2.1. Cell culture and generation of primary cells from
human samples
OSCC cell lines (Cal, H357 and CaLH3), human dys-
plastic oral keratinocyte (DOK) cell line and primary
oral cancer keratinocytes isolated from patients with
OSCC (P1 and P2) were used in this study. Written con-
sent was obtained from all patients, and the project was
approved by the Regional Committee for Ethics in
Research in West Norway.
2.2. Adhesion to collagen IV
Tissue culture dishes (100 mm, Nunc, Denmark) were
coated evenly with 10 lg/mL human collagen IV
(Sigma, St. Louis, MO, United States of America
(USA)) diluted in 10 mM acetic acid. Single cell suspen-
sions in routine culture medium were allowed to attach
to the collagen IV coated dishes in the incubator. Cells
that attached within 10 min were collected after trypsin-
isation and referred to as rapid adherent cells (RAC).
Cells that remained unattached within first 10 min were
transferred to a new collagen IV-coated dish for addi-
tional 30 min in the incubator. Cells that adhered within
this period were collected as middle adherent cells
(MAC). Remaining unattached cells were then again
transferred into a new collagen IV-coated dish for next
4 h. Adherent cells in this time period were collected
and referred to as late adherent cells (LAC).
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2.3. Colony and sphere formation assays
Five hundred cells per well were seeded in 6-well
plates (Nunc) in 3 mL complete culture medium. After
7–10 days, the wells were examined microscopically
and stained with 0.5% crystal violet (Sigma). Colonies
were manually counted. For sphere formation assay,
500 cells per well were seeded in 24-well plates (Nunc)
with 500 lL routine culture medium containing 1%
methylcellulose (Sigma). After 7–14 days, wells were
examined microscopically and viable spheres were man-
ually counted. Colony forming efficiency (CFE, %) and
sphere forming efficiency (SFE, %) were calculated using
the following formula: (average of colonies or spheres
per well/500)  100.
2.4. Tongue xenotransplantation in NOD-SCID mice
NOD-SCID 6–8 week old mice were used and main-
tained in an isolation facility under a pathogen free envi-
ronment with standard 12/12 h day and night cycle.
RAC, MAC and LAC cells isolated from P1 and P2 were
suspended in 50 lL Matrigel (BD Biosciences) andA 
C
Fig. 1. Cell morphology and in vitro self-renewal ability of different sub-p
oral squamous cell carcinoma (OSCC) patients and OSCC-cell lines. (A) Qu
sub-populations isolated based on differential subsequent adhesion to co
colony formation ability. (D) Quantification of sphere formation efficien
*P < 0.05 when compared with rapid adherent cells (RAC).transplanted into the tongue of mice (n = 91). All mice
in each group were sacrificed at the same time. Tumour
formation and loco-regional lymph node metastasis were
assessed. All animal procedures were approved by the
Norwegian Animal Research Authority.
Cell diameter measurement, cell migration assay,
immunohistochemical staining, RNA extraction, poly-
merase chain reaction (PCR) array, quantitative PCR
(qPCR), western blot, flow cytometry and cell cycle
analysis are described in Supplementary information.
3. Results
3.1. RAC cells were smaller, more homogenous and had
increased self-renewal ability
Quantification of the cell diameter showed that RAC
cells were significantly smaller than MAC and LAC
(Fig. 1A), both in oral dysplastic and OSCC cell lines,
as well as in primary OSCC-derived cells. RAC cells dis-
played a regular round shape and were more homoge-
nous when compared with MAC and LAC that were
bigger, heterogeneous and brighter, as seen under bright
field microscopy (Fig. 1B). Assessment of the in vitro
self-renewal ability showed that RAC had significantly
higher clonogenicity when compared with MAC, LACB 
D 
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Fig. 2. Tumour initiation and loco-regional metastasis after tongue xenotransplantation in NOD-SCID mice of different sub-populations in
primary cells derived from oral squamous cell carcinoma (OSCC) patients. (A) Quantification of tumour incidence. (B) Haematoxylin and eosin
(H&E) staining and immunohistochemistry staining of p53 of tongue tumours after orthotopic tongue injections with 102 cells of rapid adherent
cells (RAC), middle adherent cells (MAC) and late adherent cells (LAC) isolated from primary OSCC-derived cells (P1). Top two panels: H&E
staining for tongue tumours with low magnification (2.5) and high magnification (20); Low two panels: immunohistochemistry staining of p53
for tongue tumours with low magnification (2.5) and high magnification (20). (C) Quantification of the loco-regional lymph node metastasis.
(D) Immunohistochemistry staining of p53 for lymph nodes after orthotopic tongue injections with 102 cells of RAC, MAC and LAC isolated from
primary OSCC-derived cells (P1) with low magnification (20) and high magnification (40).
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OSCC cell lines, and for primary OSCC-derived cells
(Fig. 1C and S). Sphere formation assay showed that
RAC formed higher number of oro-spheres than MAC,
LAC and control cells in OSCC cell lines (Fig. 1D).
3.2. RAC had increased in vivo tumourigenic and
metastatic ability in primary OSCC-derived cells
A total of 91 mice were injected with different cell
subpopulations isolated from two patients with OSCC,
at serial dilutions (100, 1000 and 10,000 cells). RAC
showed increased tumour initiating ability when com-
pared to MAC and LAC (Fig. 2A and Table S1), while
MAC and LAC had lower tumour initiation ability, and
this was more obvious at higher dilutions. Tumour
growth curves showed that RAC induced the biggest
tongue tumours with the fastest tumour growth
(Fig. 3). Of note, only tumours developed by RACexhibited small islands of invading cells at the tumour
front (Fig. 2B – a, d, g and j), while MAC (Fig. 2B –
b, e, h and k) and LAC (Fig. 2B – c, f, i, and l), when
they developed tumours, had a less aggressive pattern
of invasion, more of the ‘pushing’ type tumour front,
with no single cells or small islands invading the sur-
rounding musculature. Examination of the loco-regional
lymph nodes (Fig. 2D) demonstrated the presence of
p53-positive human cells at a higher rate in the lymph
nodes of mice injected with RAC (Fig. 2D – a and d),
than in the mice injected with MAC (Fig. 2D – b and
e) or LAC (Fig. 2D – c and f).
3.3. RAC showed higher expression of stem cell-related
markers
Flow cytometry analysis of integrin b1 expression, a
known stem cell marker in normal epidermis and a colla-
gen IV receptor when heterodimerised with integrin a2
Fig. 3. Tumour growth rates when different numbers of cells from two primary oral squamous cell carcinoma (OSCC)-derived cells injected into
the tongue of NOD-SCID mice. (A) Tumour growth rates when 102 cells from P1 were injected. (B) Tumour growth rates when 103 cells from P1
were injected. (C) Tumour growth rates when 103 cells from P2 were injected. (D) Tumour growth rates when 104 cells from P2 were injected.
Values in (A) and (B) are the mean ± standard error (SEM).
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than MAC and LAC in all OSCC cell lines and primary
cells (Fig. 4A and B). Immunohistochemical staining for
P75NTR, a surface marker more recently related with
stemness in normal oral epithelium showed higher
expression in RAC than MAC and LAC for all cell lines
(Fig. 4C). Western blot for a self-renewal related mole-
cule, BMI1, revealed a higher level in RAC compared
to MAC or LAC (Fig. 4D). To characterise more pre-
cisely the expression of stem cell-related molecules in
the three cell sub-populations, 84 genes related to stem
cell properties were analysed using a PCR array in
primary OSCC-derived cells (P1). Unsupervised hierar-
chical clustering revealed distinct separation of RAC
from LAC (Fig. 5A). In addition, MAC also clustered
separately from LAC (Fig. 5B), but not from RAC
(Fig. 5C). Pair-wise significance analysis of microarrays
(SAM) analysis showed that genes related to the stem cell
properties were differently expressed in RAC and MAC
compared to LAC (Table S2). Compared to LAC,
RAC were found to have significantly (FDR = 0) up-
regulated expression of ABCG2, CCND2, PPARG,
FGF2, DVL, RPL13A, GJA1 and GDF (Table S2).
Differential gene expression pattern between RAC,
MAC and LAC was further independently verified by
quantitative real-time PCR (qRT-PCR) using TaqManassays. In line with the PCR array results, RAC
expressed significantly higher mRNA level of FGF2,
PPARG, CCDN2, TERT and RPL13A (Fig. 5D) than
LAC. The expression of BMP1 was found to be
significantly lower in RAC than LAC (Fig. 5D). Further-
more, RAC expressed significantly higher levels of
NGFR and POU5 F1 than LAC (Fig. 5E), however, no
significant differences of CD44, BMI-1, and PDPN
mRNA expression were found in RAC, MAC and
LAC (Fig. 5E).
3.4. RAC displayed migratory behaviour and higher
viability than FACS sorted CD44 high cells
Flow cytometry analysis after staining the three cell
sub-populations for DNA content showed an increase
in the proportion of cells in G2-phase of the cell cycle
in RAC compared to MAC and LAC for all cell lines
(Fig. 6A). Transwell migration assay showed that
RAC had significantly higher rate of migration than
MAC and LAC, consistent for all cells examined in
the study (Fig. 6B and C).
When compared with TICs isolated based on the
established method of FACS sorting for CD44 [13],
the viability of RAC was significantly higher than that
of CD44high cells (Table 1).
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Fig. 4. Expression of stem cell-related markers in different sub-populations in dysplastic oral keratinocytes, primary cells isolated from oral
squamous cell carcinoma (OSCC) patients, and OSCC cell lines. (A) Quantification of integrin b1 expression. (B) Flow cytometry analysis for b1-
integrin expression in H357. (C) Quantification of proportion of P75NTR positive cells in rapid adherent cells (RAC), middle adherent cells (MAC)
and late adherent cells (LAC) from oral dysplastic and OSCC cell lines, as well as primary OSCC-derived cells. (D) Western blot for BMI1 in RAC,
MAC and LAC from OSCC-derived cell line H357. Values are the mean ± standard error (SEM) (n P 3). **P < 0.01. *P < 0.05 when compared
with RAC. MFI, median fluorescence intensity.
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Many studies have showed that extracellular matrix
(ECM), as an essential component of both normal and
cancer stem cell niches, plays a crucial role in maintain-
ing stem cell properties [14]. Collagen IV is an important
ECM component and its expression pattern in the base-
ment membrane of OSCC was associated with cervical
lymph node metastasis as an important predictor of
the metastatic aggressiveness of OSCC [15]. The present
study describes, for the first time to our knowledge, the
use of a simple, non-invasive and functional method to
yield viable TICs in OSCC, based on rapid adherence
to collagen IV. We show here that OSCC cells that
adhered to collagen IV coated plates within 10 min dis-
played a number of stem cell properties, including small
cell size, high in vitro self-renewal ability, high in vivo
tumour initiating ability, high expression of stem cell
markers as well as a high proportion of cells in the G2
cell cycle phase and high migratory capability. Previous
studies suggested that cell size was related to cell pheno-
type, cell differentiation and proliferative potential inhuman keratinocytes [16]. The finding that RAC were
smaller in size and showed higher expression of stem
cell-related markers is in line with the previous study
on human corneal epithelium which showed that small
cells were expressing stem cell-associated markers and
the small cell size represented one of the important stem
cell properties while larger cells were more differentiated
cells [17]. From the stem-cell markers assessed in this
study, integrin b1 is of particular importance. It is well
known that integrin b1 functions as the major receptor
for basement membrane components such as collagen
IV when heterodimerised with integrin a2, and laminin
5 when heterodimerised with integrin a3 [18]. Early
studies showed that FACS for cells highly expressing
integrin b1 can be used to isolate normal human epider-
mal stem cells from transit amplifying cells, since the
cells with the highest level of integrin b1 expression
showed the greatest colony formation ability [11]. In
corroboration with these studies performed on normal
epithelium, the present study shows that in a malignant
epithelium the cells displaying the highest level of inte-
grin b1 (RAC) also had the highest colony formation.
Fig. 5. Expression of stem cell-related markers in different sub-populations in primary cells isolated from primary oral squamous cell carcinoma
(OSCC) cells P1. (A) Unsupervised hierarchical clustering of polymerase chain reaction (PCR) array for stem cell-related genes between rapid
adherent cells (RAC) and late adherent cells (LAC), middle adherent cells (MAC) and LAC (B) as well as RAC and MAC (C). (D) Quantitative
polymerase chain reaction (QPCR) analysis of mRNA level of FGF2, PPARG, CCDN2 TERT and RPL13A in the RAC, MAC and LAC. (E)
Quantification of mRNA expression of stem cell-related markers CD44, NGFR, BMI-1, PDPN and POU5 F1 in RAC, MAC and LAC. Values are
the mean ± standard error (SEM) (n P 3). **P < 0.01. *P < 0.05 when compared with RAC.
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tion ability, we show that the brightest integrin b1 cells
(RAC) have also the highest tumour initiating abilities.
In the present study we used orthotopic tongue xeno-
transplantation in NOD-SCID mice. This model was
chosen because the human xenotransplantation cells
are allowed, in the immunocompromised animal mod-
els, to develop and form tumours that mirror the pheno-
typic heterogeneity of the original human tumour, thus
being still considered the ‘gold standard model’ for test-
ing tumour initiating properties [19]. Despite the fact
that the most common model for tumourigenesis testing
is the subcutaneous xenotransplantation model, we have
chosen the orthotopic tongue model, since in this way
we could evaluate the loco-regional lymph node meta-
static ability, this type of metastasis being the most com-
mon in OSCC.Additional stem cell traits were also shown in this
study for the RAC cells, including the higher proportion
of cells in G2 phase of the cell cycle, consistent for all
cell lines tested. Human malignant epithelial cells with
stem-like properties were shown previously to spend a
longer time in G2 phase in order to escape apoptosis
by activating G2/M checkpoint proteins and thus pro-
vide more time for repair of DNA damage [13]. We
did not investigate the ability of RAC cells to resist
apoptosis compared to MAC and LAC, but based on
the cell cycle analysis it is expected that they will show
increased resistance. However, this needs to be further
tested.
More recently, EMT features were attributed to stem-
like cells in carcinomas, including OSCC [20]. We have
assessed here the in vivo migratory/metastasising poten-
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Fig. 6. Cell cycle analysis and cell migration of different sub-populations in dysplastic oral keratinocytes, primary cells isolated from oral squamous
cell carcinoma (OSCC) patients and OSCC cell lines. (A) Quantification of the G2 cell cycle phase by flow cytometry analysis. (B) Quantification of
the migratory capability. (C) Images of migrated cells amongst different sub-populations (magnification 4). Values are the mean ± standard error
(SEM) (n P 3). **P < 0.01. *P < 0.05 when compared with rapid adherent cells (RAC).
Table 1
Comparison of viability for isolating tumour-initiating cells (TICs) by
fluorescence-activated cell sorting (FACS) sorting based on CD44 and
collagen IV adherent assay. Values are the mean ± standard error
(SEM) (n P 3).
Method of cancer stem cell (CSC)
enrichment
% of viable cells
(average ± SEM)
FACS sorting
CD44high 76.2 ± 2.57
CD44low 67.17 ± 10.40
Adhesiveness to collagen IV
Rapid adherent cells (RAC) 89.02 ± 2.84*
Middle adherent cells (MAC) 90.69 ± 2.43
Late adherent cells (LAC) 85.0 ± 6.25
* P < 0.05 when compared with RAC.
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nodes 74 days after tongue xenotransplantation. To
visualise the human malignant cells present in the lymph
nodes we have used IHC staining with a human specific
antibody for mutated p53 (the primary cells injected in
mice were chosen after sequencing of TP53 and only
cells derived from TP53 mutated tumours were used
for this purpose), that specifically identifies these cells
and not mouse cells. Our results showed that RAC cells
have the highest in vivo migratory/metastasising
potential since the rate of cervical lymph nodes with
scattered p53-positive human cells was higher in mice
injected with RAC than in mice injected with MAC or
LAC, fulfilling thus one more criteria recently linked
to stemness in carcinomas.
Although isolated from tumours of the same
histological type and clinical staging, in vivo tumourformation and especially the metastasising ability varied
between the two primary cell lines used in the study. For
example, no tumours were formed when 100 cells from
MAC P2 cells were injected in six mice (Fig. 2A,
Table S1). Of interest, we have detected p53-positive
human migratory cells in the lymph nodes of five of
these mice (Fig. 2C and D, Table S1). This could be a
methodological bias, since for comparison reasons we
have sacrificed all mice at the same time point, when
the RAC tumours were too large and impaired the well-
being of the mice. It might be that at this time point the
primary tumours formed by the 100 MAC cells injected
were too small to be detected, although migratory
p53-positive human cells could be histologically detected
in the lymph nodes. This might be taken as an indication
that migration of malignant cells to the lymph
nodes happens quiet early in the process of
tumourigenesis, or at least in our experimental model
of tumourigenesis.
Taken together, the findings presented here show that
the cells rapidly adherent to collagen IV are enriched for
cells with stem cell-like properties, and suggest that the
method based on the adhesiveness of collagen IV pro-
vides a low cost, non-invasive, functional alternative to
FACS for isolation and enrichment of TICs in OSCCs.
The sub-population being rapidly adherent to collagen
IV could be further used to explore stem cell and tumour
initiating properties, improving our knowledge of OSCC
biology.
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